Nitric Oxide Impairs Normoxic Degradation of HIF-1α by Inhibition of Prolyl Hydroxylases
Open accessThe DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
Abstract
Hypoxia inducible factor-1 (HIF-1) is the master regulator of metabolic adaptation to hypoxia. It is appreciated that HIF-1alpha accumulation is achieved under normoxic conditions by e.g., nitric oxide. We determined molecular mechanisms of HIF-1alpha accumulation under the impact of S-nitrosoglutathione (GSNO). In human embryonic kidney cells GSNO provoked nuclear accumulation of HIF-1alpha. This appeared unrelated to gene transcription and protein translation, thus pointing to inhibition of HIF-1alpha degradation. Indeed, GSNO as well as the hypoxia mimic CoCl2 decreased ubiquitination of HIF-1alpha and GSNO-induced HIF-1alpha failed to coimmunoprecipitate with pVHL (von Hippel Lindau protein). Considering that HIF-1alpha-pVHL interactions require prolyl hydroxylation of HIF-1alpha, we went on to demonstrate inhibition of HIF-1alpha prolyl hydroxylases (PHDs) by GSNO. In vitro HIF-1alpha-pVHL interactions revealed that GSNO dose-dependently inhibits PHD activity but not the interaction of a synthetic peptide resembling the hydroxylated oxygen-dependent degradation domain of HIF-1alpha with pVHL. We conclude that GSNO-attenuated prolyl hydroxylase activity accounts for HIF-1alpha accumulation under conditions of NO formation during normoxia and that PHD activity is subject to regulation by NO.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In line with earlier findings (Metzen et al., 2003), we observed that LPS-triggered HIF1 a accumulation was partially reduced in DC treated with the inducible nitric oxide (NO) synthase 2 ( Nos2 ) inhibitor L-NIL (Figures 2L and S2D).”
From Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen (2015) · cites this paper as Metzen et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535 · cited 2×
“The impact of GSNO on PHD activity was tested in a GalDBD-HIF-1 549–582-pVHL in vitro interaction assay, performed as described previously (Jaakkola et al., 2001).”
BackgroundMethodThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180 · cited 2×
“The requirement of pVHL for HIF-1 degradation is underscored in cells that do not contain a functional pVHL, which leads to high levels of HIF-1 in normoxia (Maxwell et al., 1999; Krieg et al., 2000; Clifford et al., 2001).”
BackgroundHIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735 · cited 2×
“In normoxia HIF-1α is hydroxylated at Pro564 and Pro402 which is required for pVHL binding (Ivan et al., 2001; Jaakkola et al., 2001; Masson et al., 2001; Yu et al., 2001).”
BackgroundEpstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationBiochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549 · cited 1×
“The human enzymes have been termed prolyl hydroxylase domain containing protein 1, 2, and 3 (PHD1, PHD2, and PHD3; Epstein et al., 2001) or HIF1 prolyl hydroxylase 1, 2, and 3 (Bruick and McKnight, 2001).”
Huang, L. E., Gu, J., Schau, M., & Bunn, H. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.7987 · Cited by 2,113 · cited 1×
“Consequently, HIF-1 is polyubiquitinated and degraded by the 26S proteasome system, thus accounting for its low normoxic level of expression (Salceda and Caro, 1997; Huang et al., 1998; Kallio et al., 1999).”
BackgroundPurification and Characterization of Hypoxia-inducible Factor 1
Wang, G. L., & Semenza, G. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.3.1230 · Cited by 2,073 · cited 1×
“HIF-1 is composed of the two basic helix-loop-helix-Per-Arnt-Sim (bHLH-PAS) proteins HIF-1 and the aryl hydrocarbon receptor nuclear translocator (ARNT), also known as HIF-1 (Wang and Semenza, 1995).”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Cited by
Items 101–200 of 411
Oxidative Damage Precedes Nitrative Damage in Adriamycin-Induced Cardiac Mitochondrial Injury
Chaiswing, L., Cole, M. P., Clair, D. K. S., Ittarat, W., Szweda, L. I., & Oberley, T. D. (2004) · Toxicologic Pathology · doi:10.1080/01926230490502601 · Cited by 116
“Under pathological conditions, 3NT has been suggested to modify both translational and posttranslational protein processes (Hanafy et al., 2001; Metzen et al., 2003; Willard et al., 2003).”
BackgroundEndogenous 2-oxoacids differentially regulate expression of oxygen sensors
DALGARD, C. L., LU, H., MOHYELDIN, A., & VERMA, A. (2004) · Biochemical Journal · doi:10.1042/bj20031647 · Cited by 107
Griffiths, E. A., Pritchard, S. A., Valentine, H. R., Whitchelo, N., Bishop, P. W., Ebert, M. P., Price, P. M., Welch, I. M., & West, C. M. L. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603524 · Cited by 107
“Also, NO was shown to interfere with HIF-1 α prolyl hydroxylases under normoxia, preventing degradation and resulting in HIF-1 α accumulation and activation (”
Increased expression of HIF-1α, nNOS, and VEGF in the cerebral cortex of anemic rats
McLaren, A. T., Marsden, P. A., Mazer, C. D., Baker, A. J., Stewart, D. J., Tsui, A. K. Y., Li, X., Yücel, Y. H., Robb, M. J., Boyd, S. R., et al. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00403.2006 · Cited by 116
“Conversely, under normoxic conditions NO may lead to HIF-1α protein accumulation (32; 36; 48).”
BackgroundAnemia and Cerebral Outcomes: Many Questions, Fewer Answers
Hare, G. M. T., Tsui, A. K. Y., McLaren, A. T., Ragoonanan, T. E., Yu, J. L., & Mazer, C. D. (2008) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318184cfe9 · Cited by 112
ROS signalling between endothelial cells and cardiac cells
Zhang, M., & Shah, A. M. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu050 · Cited by 111
S-nitrosylation in the regulation of gene transcription
Sha, Y., & Marshall, H. E. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.05.008 · Cited by 101
The role of HIF prolyl hydroxylases in tumour growth
Jokilehto, T., & Jaakkola, P. M. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01030.x · Cited by 101
“The normoxic stabilization of HIF is likely to occur by direct inhibition of the PHD2 enzymatic activity perhaps by affecting the oxidation of iron [73, 74].”
BackgroundSalminen, A., Kauppinen, A., & Kaarniranta, K. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1978-z · Cited by 99
“[59] demonstrated that the NO treatment inhibited the”
BackgroundHypoxia-mediated drug resistance in breast cancers
McAleese, C. E., Choudhury, C., Butcher, N. J., & Minchin, R. F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.045 · Cited by 106
Nitric oxide delivery to cancer: Why and how?
Sonveaux, P., Jordan, B. F., Gallez, B., & Féron, O. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.12.018 · Cited by 113
“It competes with oxygen for the catalytic iron centre of PHD2, thereby reducing HIF-1a ubiquitylation and degradation to mimic hypoxia under aerobic conditions.(107) NO also readily reacts with super-”
BackgroundRegulation of redox signaling in HIF‐1‐dependent tumor angiogenesis
Manuelli, V., Pecorari, C., Filomeni, G., & Zito, E. (2022) · The FEBS Journal · doi:10.1111/febs.16110 · Cited by 96
The Akt1-eNOS Axis Illustrates the Specificity of Kinase-Substrate Relationships in Vivo
Schleicher, M., Yu, J., Murata, T., Derakhshan, B., Atochin, D., Qian, L., Kashiwagi, S., Di Lorenzo, A., Harrison, K. D., Huang, P. L., et al. (2009) · Science Signaling · doi:10.1126/scisignal.2000343 · Cited by 97
Asikainen, T. M., Ahmad, A. M., Schneider, B. K., Ho, W., Arend, M., Brenner, M. C., Günzler, V., & White, C. W. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.12.004 · Cited by 107
Complex Role of Heme Oxygenase-1 in Angiogenesis
Dulak, J., Łoboda, A., Zagórska, A., & Józkowicz, A. (2004) · Antioxidants and Redox Signaling · doi:10.1089/1523086041797980 · Cited by 93
Nitric Oxide Synthase-2-Derived Nitric Oxide Drives Multiple Pathways of Breast Cancer Progression
Basudhar, D., Somasundaram, V., de Oliveira, G. A., Kesarwala, A. H., Heinecke, J. L., Cheng, R. Y. S., Glynn, S. A., Ambs, S., Wink, D. A., & Ridnour, L. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6813 · Cited by 100
“NO directly interacts with the nonheme Fe site to inhibit PHD activity (82).”
BackgroundJežek, P., Plecitá‐Hlavatá, L., Smolková, K., & Rossignol, R. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.008 · Cited by 109
“Expression of COX4-2 is increased, whereas COX4-1, which otherwise optimizes COX activity under aerobic conditions, is degraded by the mitochondrial LON protease induced by HIF (Fukuda et al., 2007; Metzen et al., 2003).”
BackgroundHypoxia-Inducible Histone Lysine Demethylases: Impact on the Aging Process and Age-Related Diseases
Antero, S., Kai, K., & Anu, K. (2016) · Aging and disease · doi:10.14336/ad.2015.0929 · Cited by 89
“[67] Metzen E, Zhou J, Jelkmann W, Fandrey J, Brüne B (2003).”
BackgroundShould I stay or should I go: β-catenin decides under stress
Hoogeboom, D., & Burgering, B. M. T. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.02.002 · Cited by 106
Ott, L. W., Resing, K. A., Sizemore, A. W., Heyen, J. W., Cocklin, R., Pedrick, N. M., Woods, H. C., Chen, J. Y., Goebl, M. G., Witzmann, F. A., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr060665l · Cited by 101
HIF-1α as a central mediator of cellular resistance to intracellular pathogens
Knight, M., & Stanley, S. A. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.05.005 · Cited by 93
Oxygen-dependent regulation of nitric oxide production by inducible nitric oxide synthase
Robinson, M. A., Baumgardner, J. E., & Otto, C. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.034 · Cited by 96
Zhang, L., Sun, Z., Bian, Y., & Kulkarni, A. B. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.003 · Cited by 87
“Meanwhile, recent studies also suggest that HIF-1α can be accumulated and activated by certain stimuli under normoxic conditions [49,50], and may involve the degradation of FIH [49].”
BackgroundIs the hypoxia-inducible factor pathway important in gastric cancer?
Griffiths, E. A., Pritchard, S., Welch, I., Price, P., & West, C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.09.008 · Cited by 88
“NO has been shown to interfere with HIF-1a prolyl hydroxylases under normoxia, preventing degradation and resulting in HIF-1a accumulation and activation [47].”
BackgroundChen, J., & Stinnett, A. (2008) · Diabetes · doi:10.2337/db08-0503 · Cited by 86
“phosphatidylinositol 3-kinase signaling (35,36) and the NO-dependent inhibition of PHD activity (17,37) have been shown to contribute to HIF-1 stabilization.”
BackgroundMolecular mechanisms of ischemic preconditioning in the kidney
Kapitsinou, P. P., & Haase, V. H. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00224.2015 · Cited by 81
“NO-mediated HIF activation is therefore likely to contribute to the cytoprotective effects of NO in IPC (110).”
BackgroundAndré, A. C., Debande, L., & Marteyn, B. (2021) · Cellular Microbiology · doi:10.1111/cmi.13338 · Cited by 120
iNOS as a therapeutic target for treatment of human tumors
Fitzpatrick, B., Mehibel, M., Cowen, R. L., & Stratford, I. J. (2008) · Nitric Oxide · doi:10.1016/j.niox.2008.05.001 · Cited by 88
Park, J., Hwang, M., Suh, S., & Baek, W. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00678.x · Cited by 86
“Reverse transcriptase–polymerase chain reaction (RT–PCR) reactions were performed as described previously [31].”
MethodOleksiewicz, U., Liloglou, T., Field, J. K., & Xinarianos, G. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0764-9 · Cited by 89
“Cygb as NOD may also modulate NO concentration [58] in a cancer setting and thus affect HIF1a stability and signalling [65, 67, 92, 93].”
BackgroundRegulation of Cellular Gas Exchange, Oxygen Sensing, and Metabolic Control
Clanton, T. L., Hogan, M. C., & Gladden, L. B. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120030 · Cited by 80
Chintala, S., Najrana, T., Toth, K., Cao, S., Durrani, F. A., Pili, R., & Rustum, Y. M. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-293 · Cited by 79
“These include enhanced levels of reactive oxygen species (ROS) [15], nitric oxide [16,17], 2-oxoglutarate, Fe (II), ascorbate, fu-”
BackgroundOxygen-sensing under the influence of nitric oxide
Berchner‐Pfannschmidt, U., Tug, S., Kirsch, M., & Fandrey, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.10.004 · Cited by 89
Self-citationHemoglobin: A Nitric-Oxide Dioxygenase
Gardner, P. R. (2012) · Scientifica · doi:10.6064/2012/683729 · Cited by 85
Peng, Z., Ren, P., Kang, Z., Du, J., Lian, Q.-L., Liu, Y., Zhang, J. H., & Sun, X. (2008) · Brain Research · doi:10.1016/j.brainres.2008.03.027 · Cited by 83
“ROS interfere with hydroxylase activity and lead to HIF-1α accumulation (Metzen et al., 2003).”
Hydrogen sulfide inhibits the translational expression of hypoxia‐inducible factor‐1α
Wu, B., Teng, H., Yang, G., Wu, L., & Wang, R. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02113.x · Cited by 75
“A wide range of stimuli and cytokines have been shown to affect HIF-1a protein stability, including two gasotransmitters, NO (Hagen et al., 2003; Metzen et al., 2003) and carbon monoxide (CO) (Choi et al.”
BackgroundInfluentialTsui, A. K. Y., Marsden, P. A., Mazer, C. D., Adamson, S. L., Henkelman, R. M., Ho, J. J. D., Wilson, D. F., Heximer, S. P., Connelly, K. A., Bolz, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114026108 · Cited by 75
Blanco, S., Hernández, R., Franchelli, G., Ramos‐Álvarez, M. M., & Peinado, M. Á. (2016) · Nitric Oxide · doi:10.1016/j.niox.2016.12.001 · Cited by 79
Regulation of BNIP3 in Normal and Cancer Cells
Lee, H., & Paik, S.-G. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)12896-2 · Cited by 74
Kuwabara, M., Kakinuma, Y., Ando, M., Katare, R., Yamasaki, F., Doi, Y., & Sato, T. (2006) · The Journal of Physiological Sciences · doi:10.2170/physiolsci.rp002305 · Cited by 81
Farahani, A., Farahani, A., Kashfi, K., & Ghasemi, A. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107781 · Cited by 89
“Hypoxic conditions inhibit PHD activity, allowing HIF-1 α stabilization, dimerization with HIF-1 β , and transcriptional activation of target genes, including NOS2 [89,90,94].”
InfluentialEndothelial–cardiomyocyte crosstalk enhances pharmacological cardioprotection
Leucker, T. M., Bienengraeber, M., Muravyeva, M., Baotic, I., Weihrauch, D., Brzezinska, A. K., Warltier, D. C., Kersten, J. R., & Pratt, P. F. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.06.026 · Cited by 72
“Although the activity of PHD is oxygen-dependent, this enzyme is also regulated by ROS and NO [37].”
BackgroundDe Sanctis, F., Sandri, S., Ferrarini, G., Pagliarello, I., Sartoris, S., Ugel, S., Marigo, I., Molon, B., & Bronte, V. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00069 · Cited by 71
“Furthermore, the increased production of NO establishes a positive feedback loop on HIF1-α levels: NO-dependent impaired activity of PHD stabilizes HIF1-α and NF-κB, thus amplifying the expression of genes under their control, even under physiologic oxygen environments (89).”
BackgroundMoeinabadi-Bidgoli, K., Babajani, A., Yazdanpanah, G., Farhadihosseinabadi, B., Jamshidi, E., Bahrami, S., & Niknejad, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112026 · Cited by 70
Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1α stabilization
Köhl, R., Zhou, J., & Brüne, B. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.012 · Cited by 77
Self-citationLi, T., & Brouwer, M. H. (2007) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2006.12.018 · Cited by 68
“The gene of the inducible form of nitric oxide synthase (iNOS) is upregulated by HIF and NO impairs normoxic degradation of HIF-1α by inhibition of prolyl hydroxylases (Melillo et al., 1995; Metzen et al., 2003 ).”
BackgroundChowdhury, R., Flashman, E., Mecinović, J., Kramer, H., Kessler, B. M., Frapart, Y., Boucher, J., Clifton, I. J., McDonough, M. A., & Schofield, C. J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.075 · Cited by 70
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation
Lopez‐Ramirez, M. A., Soliman, S. I., Hale, P., Lai, C. C., PHAM, A., Estrada, E. J., McCurdy, S., Girard, R., Verma, R., Moore, T., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139570 · Cited by 73
“Because NO can reach cells millimeters away from where it is produced, this in turn can stabilize HIF-1α protein (85, 86) from degradation by several mechanisms directly by HIF-1α nitrosylation or also indirectly by increasing production of reactive oxidative CCM endothelium and astrocytes drives lesion development.”
Galkin, A., Higgs, A., & Moncada, S. (2007) · Essays in Biochemistry · doi:10.1042/bse0430029 · Cited by 65
Hypoxia-Inducible Factor in Thyroid Carcinoma
Burrows, N., Babur, M., Resch, J., Williams, K. J., & Brabant, G. E. (2011) · Journal of Thyroid Research · doi:10.4061/2011/762905 · Cited by 74
Chandramani Shivalingappa, P., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. (2012) · Parkinson's Disease · doi:10.1155/2012/424285 · Cited by 61
“Hindawi Publishing Corporation Parkinson’s Disease Volume 2012, Article ID 424285, 11 pages doi:10.1155/2012/424285”
BackgroundInfluentialNitric oxide and tumor metabolic reprogramming
Lopez-Sanchez, L. M., Aranda, E., & Rodríguez‐Ariza, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113769 · Cited by 68
Charron, C. E., Chou, P.-C., Coutts, D. J. C., Kumar, V., To, M., Akashi, K., Pinhu, L., Griffiths, M., Adcock, I. M., Barnes, P. J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025387 · Cited by 64
Callapina, M., Zhou, J., Schnitzer, S. E., Metzen, E., Lohr, C., Deitmer, J. W., & Brüne, B. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.02.018 · Cited by 67
“It is supposed that NO directly blocks PHDs based on the knowledge that they require Fe for enzymatic activity and that NO binds to Fe containing enzymes [19].”
BackgroundSelf-citationRedox-signals and macrophage biology
Weigert, A., von Knethen, A., Fuhrmann, D., Dehne, N., & Brüne, B. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.01.003 · Cited by 60
Self-citationRegulation of vitamin metabolism by p53 and p63 in development and cancer
Zhou, H., & van Bokhoven, H. (2010) · Cell Cycle · doi:10.4161/cc.9.14.12591 · Cited by 61
Calpain Mediates a von Hippel-Lindau Protein–independent Destruction of Hypoxia-inducible Factor-1α
Zhou, J., Köhl, R., Herr, B., Frank, R., & Brüne, B. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-08-0770 · Cited by 69
“Mechanistically, this is explained by direct inhibition of PHD activity (Metzen et al., 2003) and/or by enhancing phosphatidylinositol 3 kinase (PI3K)Figure 7.”
BackgroundSelf-citationBerchner‐Pfannschmidt, U., Petrat, F., Doege, K., Trinidad, B., Freitag, P., Metzen, E., de GROOT, H., & Fandrey, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313995200 · Cited by 67
Self-citationSOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α
Mira, E., Carmona‐Rodríguez, L., Pérez‐Villamil, B., Casas, J., Fernández‐Aceñero, M. J., Martínez-Rey, D., Martín-González, P., Heras‐Murillo, I., Paz-Cabezas, M., Tardáguila, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03079-1 · Cited by 64
Roberts, L. D., Ashmore, T., McNally, B. D., Murfitt, S. A., Fernandez, B. O., Feelisch, M., Lindsay, R., Siervo, M., Williams, E. A., Murray, A. J., et al. (2017) · Diabetes · doi:10.2337/db16-0843 · Cited by 57
“NO increases PGC1a expression in skeletal muscle and inhibits HIF complex prolyl hydroxylases, stabilizing the HIF complex (6,28).”
InfluentialHypoxia inducible factor-1α accumulation in steatotic liver preservation: Role of nitric oxide
Zaoualí, M. A., Mosbah, I. B., Boncompagni, E., Abdennebi, H. B., Mitjavila, M. T., Bartrons, R., Freitas, I., Rimola, A., & Roselló‐Catafau, J. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i28.3499 · Cited by 63
Nix-Mediated Mitophagy Modulates Mitochondrial Damage During Intestinal Inflammation
Vincent, G., Novak, E. A., Siow, V. S., Cunningham, K. E., Griffith, B. D., Comerford, T. E., Mentrup, H. L., Stolz, D. B., Loughran, P., Ranganathan, S., et al. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7702 · Cited by 64
“Both mtROS and nitric oxide can stabilize HIF1a by inhibition of prolyl hydroxylases (PHD) that are responsible for degradation of HIF1a, mostly under normoxic conditions (8, 36, 39).”
BackgroundTalwar, H. S., Bauerfeld, C. P., Bouhamdan, M., Farshi, P., Liu, Y., & Samavati, L. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.018 · Cited by 57
Phenolics and anthocyanins in berries of European cranberry and their antimicrobial activity
Česonienė, L., Jasutienė, I., & Šarkinas, A. (2024) · PubMed · doi:10.5281/zenodo.11174808 · Cited by 56
Induced Nitric Oxide Synthase as a Major Player in the Oncogenic Transformation of Inflamed Tissue
Yang, G.-Y., Taboada, S., & Liao, J. (2009) · Methods in Molecular Biology™ · doi:10.1007/978-1-60327-530-9_8 · Cited by 56
Dioxygenases as O2-dependent regulators of the hypoxic response pathway
Dann, C. E., & Bruick, R. K. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.140 · Cited by 62
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulation
Strocchi, S., Reggiani, F., Gobbi, G., Ciarrocchi, A., & Sancisi, V. (2022) · Oncogene · doi:10.1038/s41388-022-02378-8 · Cited by 61
Oligomycin inhibits HIF-1α expression in hypoxic tumor cells
Gong, Y., & Agani, F. H. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00443.2004 · Cited by 54
Regulation of cardiovascular cellular processes by S-nitrosylation
Schulman, I. H., & Hare, J. M. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.04.002 · Cited by 55
Park, Y.-K., Ahn, D., Oh, M., Tae-Kyoung, L., Yang, E. G., Son, M., & Park, H. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045278 · Cited by 57
“It has been suggested that S-nitrosoglutathione (GSNO) inhibits PHD2-dependent VHL recruitment of HIF-1 in normoxic conditions (Metzen et al., 2003; Berchner-Pfannschmidt et al., 2007).”
BackgroundZheng, Y., Dong, Y., Gao, B., Huang, S., Tang, Y., Wa, Q., Dong, Y., Yu, S. P., Huang, J. C., & Huang, S. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.01.026 · Cited by 56
Modulation of the Hypoxic Response
Pugh, C. W. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-7678-9_18 · Cited by 61
Khan, Z., Michalopoulos, G. K., & Stolz, D. B. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060360 · Cited by 60
Hypoxia-Inducible Factor 1 Regulates Heat and Cold Pain Sensitivity and Persistence
Kanngießer, M., Mair, N., Lim, H., Zschiebsch, K., Blees, J. S., Häußler, A., Brüne, B., Ferreirós, N., Kress, M., & Tegeder, I. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5494 · Cited by 50
“In addition to hypoxia, iron chelators, cobalt chloride, cytokines such as interleukin-1, reactive oxygen species (ROS), and nitric oxide (NO) can mimic a hypoxic response by stabilization of HIF1 a (35, 49).”
Self-citationActivation of Ras Up-regulates Pro-apoptotic BNIP3 in Nitric Oxide-induced Cell Death
An, H.-J., Maeng, O., Kang, K.-H., Lee, J.-O., Kim, Y.-S., Paik, S.-G., & Lee, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605819200 · Cited by 51
Sousa, E. H. S., Ridnour, L. A., Júnior, F. S. G., da Silva, C. D. S., Wink, D. A., Lopes, L. G. D. F., & Sadler, P. J. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00222 · Cited by 57
Dose dependent effects of cadmium on tumor angiogenesis
Wei, T., Jia, J., Wada, Y., Kapron, C. M., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16572 · Cited by 53
Metabolic changes in bladder cancer
Woolbright, B. L., Ayres, M., & Taylor, J. A. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.04.010 · Cited by 58
Jung, H.-J., Park, J., Lee, J. S., Lee, S., Jang, B., Suh, S., Suh, M., & Baek, W. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.068 · Cited by 49
Wenger, R. H., & Kurtz, A. (2011) · Comprehensive physiology · doi:10.1002/cphy.c100075 · Cited by 61
Khan, M., Dhammu, T. S., Matsuda, F., Baarine, M., Dhindsa, T. S., Singh, I., & Singh, A. K. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s77115 · Cited by 50
Chowdhury, R., Godoy, L. C., Thiantanawat, A., Trudel, L. J., Deen, W. M., & Wogan, G. N. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300274a · Cited by 49
Shlomai, J. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.3029 · Cited by 47
Hirota, S. A., Beck, P. L., & MacDonald, J. A. (2009) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221309787158434 · Cited by 57
“However, SNAP also inhibited FIH-1-dependent asparagine hydroxylation, allowing for full interaction of HIF-1 with its co-activators CBP/p300 [76].”
BackgroundInfluentialHirota, K. (2020) · Biomedicines · doi:10.3390/biomedicines8020032 · Cited by 59
“NO decreases PHD activity and inhibits HIF-1α ubiquitination, suggesting that hypoxia and NO adopt synergistic intracellular pathways to stabilize and increase HIF-1α [144,145].”
BackgroundHIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo
Kachamakova‐Trojanowska, N., Podkalicka, P., Bogacz, T., Barwacz, S. A., Józkowicz, A., Dulak, J., & Łoboda, A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113922 · Cited by 51
Bove, P. F., Hristova, M., Wesley, U. V., Olson, N. C., Lounsbury, K. M., & van der Vliet, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709914200 · Cited by 52
Analysis of differentially expressed genes in nitric oxide-exposed human monocytic cells
Turpaev, K. T., Bouton, C., Diet, A., Glatigny, A., & Drapier, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.002 · Cited by 50
Hypoxia Inducible Factor-1α in Osteochondral Tissue Engineering
Taheem, D. K., Jell, G., & Gentleman, E. (2019) · Tissue Engineering Part B Reviews · doi:10.1089/ten.teb.2019.0283 · Cited by 51
“PHD2 and FIH activity, at least in part, by blocking the binding of Fe to the active site, leading to similar levels of HIF-1a stabilization as those observed in CoCl2-treated cell cultures.(97,98) SNAP similarly promotes HIF-dependent gene expression by inhibiting VHL-HIF-1a binding and FIH activity,(99) and NAC has…”
BackgroundBeers, J. M., Borley, K. A., & Sidell, B. D. (2010) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2010.03.027 · Cited by 49
“These responses combine to produce anNO-mediated induction of angiogenesis (Kimura et al., 2000, 2001; Metzen et al., 2003).”
BackgroundHyperbaric oxygen preconditioning promotes angiogenesis in rat liver after partial hepatectomy
Ren, P., Kang, Z., Gu, G., Liu, Y., Xu, W., Tao, H., Zhang, J. H., Sun, X., & Ji, H. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.06.011 · Cited by 49
“Nitrosylation by reactive nitrogen leading to HIF-1α stabilization has also been implicated as a critical mechanism of induction (Wellman et al., 2004; Metzen et al., 2003).”
BackgroundNO and transcriptional regulation: from signaling to death
Zhou, J., & Brüne, B. (2004) · Toxicology · doi:10.1016/j.tox.2004.11.021 · Cited by 50
Self-citationMacrophage Motility in Wound Healing Is Regulated by HIF-1α via S1P Signaling
Hutami, I. R., Izawa, T., Khurel‐Ochir, T., Sakamaki, T., Iwasa, A., & Tanaka, E. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168992 · Cited by 52
“While pVHL has been shown to have a vital role in controlling HIF-1α stability via ubiquitination [71], a pVHL-independent pathway also exists.”
BackgroundThe Role of HIF-1α in Bone Regeneration: A New Direction and Challenge in Bone Tissue Engineering
You, J., Liu, M., Li, M., Zhai, S., Quni, S., Zhang, L., Liu, X., Jia, K., Zhang, Y., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098029 · Cited by 63
Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cells
Calahorra, J., Martínez‐Lara, E., Granadino‐Roldán, J. M., Martí, J. M., Cañuelo, A., Blanco, S., Oliver, F. J., & Siles, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-63417-6 · Cited by 49
Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning
Hieber, S., Huhn, R., Hollmann, M. W., Weber, N. C., & Preckel, B. (2009) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e3283212cbb · Cited by 47
Arginine revisited: Minireview article
GRILLO, M. A., & Colombatto, S. (2004) · Amino Acids · doi:10.1007/s00726-004-0081-9 · Cited by 44
“It has been shown that this occurs by selective increase of the expression of prolyl hydroxylase 2 mRNA levels (Berra et al., 2003), while it also seems that NO has an inhibitory role in controlling the regulation of hydroxylase activity (Metzen et al., 2003).”
Martinive, P., Defresne, F., Quaghebeur, E., Daneau, G., Crokart, N., Grégoire, V., Gallez, B., Dessy, C., & Féron, O. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06798.x · Cited by 49
Redox Regulation of Lung Development and Perinatal Lung Epithelial Function
Land, S. C., & Wilson, S. M. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.92 · Cited by 45
“Additionally, prolyl hydroxylase activity is inhibited dose-dependently by nitric oxide (NO) donation under normoxic conditions leading to HIF-1 (cid:1) accumulation in the absence of hypoxia (65, 83).”
Fletcher, S. C., & Coleman, M. L. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190333 · Cited by 55
Metadata
- Authors
- Metzen, E., Zhou, J., Jelkmann, W., Fandrey, J., & Brüne, B.
- Affiliations
- University of Lübeck (DE)
- University of Kaiserslautern (DE)
- University of Duisburg-Essen (DE)
- Venue
- Molecular Biology of the Cell
- Published
- 2003-08
- Volume
- 14
- Issue
- 8
- Pages
- 3470-3481
- ISSN
- 1059-1524 (ISSN-L)
- 1939-4586
- PMC
- PMC181582
- OpenAlex
- W2072634616
- Cited by
- 414
- References
- 63
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 10 · 2023: 13 · 2022: 7 · 2021: 22 · 2020: 13 · 2019: 12 · 2018: 9 · 2017: 12 · 2016: 23 · 2015: 19 · 2014: 10 · 2013: 14 · 2012: 17
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Molecular Biology of the Cell (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- European Molecular Biology Laboratory
- University of Oxford
- Deutsche Forschungsgemeinschaft (SFB367, BR999)
- Deutsche Krebshilfe
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- nitric oxide, HIF-1α, prolyl hydroxylase, S-nitrosoglutathione, HIF-1α degradation, ubiquitination, von Hippel-Lindau protein, oxygen-dependent degradation domain, cobalt chloride, hypoxia, protein stability
- MeSH terms
- Cells, Cultured, Humans, Nitric Oxide, Procollagen-Proline Dioxygenase, Protein Binding, Transcription Factors, Transcription, Genetic, Protein Biosynthesis, Cell Hypoxia, Tumor Suppressor Proteins, S-Nitrosoglutathione, Ubiquitin-Protein Ligases, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.